Vision Scs F2 Cullinan Oncology, Inc. (CGEM) insider trading activity
Vision Scs F2 is > 10% Shareholder of Cullinan Oncology, Inc.. Currently has a direct ownership of 1.26 Million shares of CGEM, which is worth approximately $15.3 Million. The most recent transaction as insider was on Aug 04, 2022, when has been sold 25,989 shares (Common Stock) at a price of $14.31 per share, resulting in proceeds of $371,903. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.26M
0%
3M change
0%
12M change
Total Value Held
$15.3 Million
Vision SCS F2 Transaction History
VSF
Vision Scs F2
> 10% Shareholder
Luxemburg, V8